Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2013 · 10-Q
Revenue$80.99M$80.99M−3.1% vs Q3 2012 Net Income$33.12M$33.12M+4.3% vs Q3 2012 EPS Diluted$0.90$0.90+4.7% vs Q3 2012 Gross Profit$61,147,000−3.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$33,025,000−4.2% Free Cash Flowderived$26,652,000−18.9% Margins · derivedGross margin75.5%−0.3 pt vs Q3 2012
Operating margin54.3%−1.2 pt vs Q3 2012
Net margin40.9%+2.9 pt vs Q3 2012
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end